Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 20 | 32790884 | intron variant | A/C;G;T | snv |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.080 | 20 | 32790884 | intron variant | A/C;G;T | snv |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.080 | 20 | 32807791 | missense variant | A/G | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases | 0.800 | 1.000 | 7 | 1999 | 2016 | ||||||||
|
1.000 | 0.080 | 20 | 32807782 | missense variant | A/G | snv | 7.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases | 0.700 | 1.000 | 7 | 1999 | 2016 | |||||||
|
1.000 | 0.080 | 20 | 32800255 | missense variant | A/G | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
1.000 | 0.080 | 20 | 32797284 | missense variant | A/G | snv | 4.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.160 | 20 | 32788957 | missense variant | A/G | snv | 2.8E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 20 | 32796330 | intron variant | A/G | snv | 0.49 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.827 | 0.200 | 20 | 32808730 | 3 prime UTR variant | A/G;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.827 | 0.200 | 20 | 32808730 | 3 prime UTR variant | A/G;T | snv |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.827 | 0.200 | 20 | 32808730 | 3 prime UTR variant | A/G;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.827 | 0.200 | 20 | 32808730 | 3 prime UTR variant | A/G;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.827 | 0.200 | 20 | 32808730 | 3 prime UTR variant | A/G;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
20 | 32764779 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
20 | 32775561 | intron variant | C/A;G;T | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
1.000 | 0.080 | 20 | 32780411 | stop gained | C/A;T | snv | 4.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases | 0.700 | 0 | ||||||||||
|
0.708 | 0.440 | 20 | 32786453 | intron variant | C/T | snv | 0.56 | 0.53 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2011 | 2015 | ||||||
|
0.708 | 0.440 | 20 | 32786453 | intron variant | C/T | snv | 0.56 | 0.53 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2011 | 2015 | ||||||
|
0.708 | 0.440 | 20 | 32786453 | intron variant | C/T | snv | 0.56 | 0.53 |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases | 0.020 | 1.000 | 2 | 2015 | 2018 | ||||||
|
0.708 | 0.440 | 20 | 32786453 | intron variant | C/T | snv | 0.56 | 0.53 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases | 0.020 | 1.000 | 2 | 2015 | 2018 | ||||||
|
0.708 | 0.440 | 20 | 32786453 | intron variant | C/T | snv | 0.56 | 0.53 |
|
Nervous System Diseases | 0.020 | 1.000 | 2 | 2017 | 2017 | ||||||
|
20 | 32809593 | downstream gene variant | C/T | snv | 9.4E-03 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
0.925 | 0.080 | 20 | 32772577 | intron variant | C/T | snv | 0.27 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.080 | 20 | 32772577 | intron variant | C/T | snv | 0.27 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.080 | 20 | 32772577 | intron variant | C/T | snv | 0.27 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 |